Effectiveness of Blood Flow Restricting Exercises and Isokinetic Exercises in Female Football Players
NCT ID: NCT06445478
Last Updated: 2024-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2023-04-02
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of the Blood Flow Restriction Method on Performance Parameters in Elite Volleyball Players
NCT07019168
Effect of Blood Flow Restriction on Football-Related Performance Parameters
NCT05452109
Acute Effects of Exercises Combined With Blood Flow Restriction in Healthy Individuals
NCT04206345
Acute BFR Training Effects on Balance and Proprioception
NCT07309068
The Acute Effects of Static and PNF Stretching Exercise With Blood Flow Restriction in Athletes
NCT06656858
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 (Resistant exercise with blood flow restrictive exercise (BFR-RE Group ))
Resistant exercise with blood flow restrictive exercise (BFR-RE) training will be given 2 days a week for 8 weeks. Each exercise session will consist of 4 sets. There will be 30 repetitions in the first set and 15 repetitions in the next 3 sets, for a total of 75 repetitions. There will be a minimum of 30 seconds and a maximum of 60 seconds of rest intervals between sets. Since the application will be performed for the lower extremity muscle groups, a cuff will be placed on the proximal part of the lower extremity. Exercise load will be determined as 20-40% of 1 RM.
Blood Flow Restrictive Exercise and Isokinetic Exercise
Before providing exercise training, the muscle strength, circumference measurement, joint range of motion, agility and quality of life of female football players will be determined. Muscle strength measurements will be evaluated with the Kineo Intelligent Load Isokinetic Device for the BFR-RE and ID-RE groups. Then, both groups will be given 4 weeks of resistance exercise training. After this training, all evaluations will be made again. After this evaluation, another 4 weeks of training will be given and the evaluations will be re-applied at the end of the 8th week.
The "Informed Volunteer Consent Form" will be read and signed by 30 selected participants.
Group 2 (Resistant exercise with isokinetic device (ID-RE Group))
Resistant exercise with isokinetic device (ID-RE) training will be given 2 days a week for 8 weeks. During the training, leg press, squat and knee extension movements will be improved by increasing the resistance or changing the position depending on the athlete's condition.
Blood Flow Restrictive Exercise and Isokinetic Exercise
Before providing exercise training, the muscle strength, circumference measurement, joint range of motion, agility and quality of life of female football players will be determined. Muscle strength measurements will be evaluated with the Kineo Intelligent Load Isokinetic Device for the BFR-RE and ID-RE groups. Then, both groups will be given 4 weeks of resistance exercise training. After this training, all evaluations will be made again. After this evaluation, another 4 weeks of training will be given and the evaluations will be re-applied at the end of the 8th week.
The "Informed Volunteer Consent Form" will be read and signed by 30 selected participants.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood Flow Restrictive Exercise and Isokinetic Exercise
Before providing exercise training, the muscle strength, circumference measurement, joint range of motion, agility and quality of life of female football players will be determined. Muscle strength measurements will be evaluated with the Kineo Intelligent Load Isokinetic Device for the BFR-RE and ID-RE groups. Then, both groups will be given 4 weeks of resistance exercise training. After this training, all evaluations will be made again. After this evaluation, another 4 weeks of training will be given and the evaluations will be re-applied at the end of the 8th week.
The "Informed Volunteer Consent Form" will be read and signed by 30 selected participants.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Becoming a female football player
* Volunteering to participate in the study
Exclusion Criteria
* Pregnancy
* Hypertension
* Anti-inflammatory use
* Unexplained chest pain
* Congenital heart disease
* Participants with a history of contraindications to exercise
* There is another study conducted at the same time as the study.
18 Years
30 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Medipol University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ebru Sever
Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
DOIT Health & Sports Clinic
Istanbul, Ataşehir, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
İREMNURESMANURRABİA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.